Company: PTPI
Filing Date: 2025-02-13
Form Type: S-1/A
Source: 0001410578-25-000122
Chunk: 252

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-02-13
Form: S-1/A
Chunk 252
---
 | ​           
 Convertible 
 Redeemable  
 Preferred   
 Stock       
 Amount      
 ​           |           ​ | ​ 
 ​ 
 ​ 
 ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ 
 ​ 
 ​ |          ​ 
          ​ 
     Common 
      Stock | ​ 
 ​ 
 ​ 
 ​ 
 ​ | ​      
 Common 
 Stock  
 Amount 
 ​      |     ​ 
     ​ 
     ​ | ​ 
 ​ 
 ​ 
 ​ 
 ​ | ​          
 Additional 
 Paid-in    
 Capital    
 ​          |           ​ 
           ​ 
           ​ | ​ 
 ​ 
 ​ 
 ​ 
 ​ | ​           
 Accumulated 
 Deficit     
 ​           |            ​ 
            ​ 
            ​ 
            ​ | ​ 
 ​ 
 ​ 
 ​ 
 ​ | ​     
 Total 
 ​     |          ​ 
          ​ 
          ​ 
          ​ 
          ​ |
|:--------------------------------------------------|:--|------------:|:--|:------------|------------:|:--|:--|-----------:|:--|:-------|------:|:--|:-----------|------------:|:--|:------------|-------------:|:--|:------|-----------:|
| Balance, December 31, 2023                        |   |      10,022 | ​ | $           |     408,982 | ​ | ​ |  2,991,377 | ​ | $      |   298 | ​ | $          | 110,960,324 | ​ | $           |  -98,889,581 | ​ | $     | 12,071,041 |
| Stock-based compensation expense                  |   |           — | ​ | ​           |           — | ​ | ​ |          — | ​ | ​      |     — | ​ | ​          |     197,215 | ​ | ​           |            — | ​ | ​     |    197,215 |
| Common Stock issued for services                  |   |           — | ​ | ​           |           — | ​ | ​ |    459,972 | ​ | ​      |    47 | ​ | ​          |     269,953 | ​ | ​           |            — | ​ | ​     |    270,000 |
| Series A Preferred Stock accretion                |   |           — | ​ | ​           |   9,099,230 | ​ | ​ |          — | ​ | ​      |